TSplus Cheers on “Sisters In Rose” as the Adventure Begins in the Trophée Roses des Sables 2025
DataGrail Privacy Risk Summit: As AI & Privacy Collide, Automation & Guardrails Key to Responsible AI Innovation
Doubleview Gold Corp Announces 320-Meter Eastward Extension at the Hat Polymetallic Deposit, Expanding Mineralized Volume and Remaining Open
U.S. Polo Assn. Wins Gold and Silver Stevie Awards at the 2025 International Business Awards in Lisbon, Portugal
CITIC Telecom CPC Garners CAHK STAR Award 2025 Again
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
NAMUR, Belgium–(BUSINESS WIRE)–Sunrise, the company revolutionising home sleep testing, announces a €17 million in funding….
RIVERWOODS, Ill.–(BUSINESS WIRE)–Discover Financial Services (NYSE: DFS) today announced that Jason Hanson will succeed…
Affirmative vote required on March 30, 2023 special meeting of stockholders in order for the…
Experience leaders from world’s top brands – including Disney, Chipotle, and Delta – are using…
LOS ANGELES–(BUSINESS WIRE)–Guess?, Inc. (NYSE: GES) announced today that the Company will be participating in…
LA JOLLA, Calif., March 09, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded…
MISSISSAUGA, Ontario, March 09, 2023 (GLOBE NEWSWIRE) — BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture:…
SAN DIEGO, March 09, 2023 (GLOBE NEWSWIRE) — Telesis Bio (Nasdaq: TBIO), a leader in automated…
Atlas Global Brands today announced that it has completed most of its key integration activities…
WOODCLIFF LAKE, N.J., March 09, 2023 (GLOBE NEWSWIRE) — Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) (“Eagle”…
– On Track to Provide Initial Clinical Data from Gene Editing Trial for PKU Mid-Year with…
— Preliminary data from GRANITE Phase 2/3 study (individualized vaccine for first-line microsatellite-stable colorectal cancer…
NEWARK, Calif., March 09, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage…
– Initiation of Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected in Q2…
Pipeline Focus on Pan-Caspase and Caspase Selective Inhibitors for Infectious and Inflammatory Diseases SAN DIEGO,…
SAN DIEGO and TORONTO, March 09, 2023 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (Nasdaq: APTO;…
SOUTH SAN FRANCISCO, Calif., March 09, 2023 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS),…
– Positive data from bexotegrast INTEGRIS-IPF 320 mg dose group demonstrated a continued favorable safety…
Exploring strategic partnership options to advance AMT-101 for chronic pouchitis, an orphan indication with no FDA-approved…